Search Results 6961-6970 of 25121 for oral

  1. Clinical trials - Oncology (Medical)

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  2. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  3. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  4. Publications - Timothy B. Curry, M.D., Ph.D. - Mayo Clinic

    2015 Nov-Dec; 37: (6)354-62. View PubMed; Harvey RE, Hart EC, Charkoudian N, Curry TB, Carter JR, Fu Q, Minson CT, Joyner MJ, Barnes JN. Oral Contraceptive ...

  5. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    contraception (oral contraceptive pills, implants, transdermal patches, vaginal rings or long-acting injections). ii. Women not of childbearing potential ...

  6. Publications - Tsung-Teh Wu, M.D., Ph.D. - Mayo Clinic

    Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS. 2013 Sep 10 ...

  7. Publications - Michael R. Henry, M.D. - Mayo Clinic

    Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia . J Womens Health (Larchmt) ...

  8. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  9. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  10. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    The use of an oral phosphodiesterase type 5 inhibitor, if only indicated for erectile dysfunction, is permitted, if not administered within 48 hours of a ...